Features of the clinical course of CAD in patients with COVID-19, depending on the presence of metabolic syndrome
Gulnora AbdievaAssistant of the Department of Internal Diseases and cardiology №2, Samarkand State Medical University, Samarkand, Uzbekistan,Ташкенбаева Элеонора НегматовнаDSc, professor head of the Department of Internal Diseases and cardiology №2, Samarkand State Medical University, Samarkand, Uzbekistan,Sukhrobjon EllamonovAssistant of the Department of Internal Diseases №3, Samarkand State Medical University, Samarkand, Uzbekistan
2023en
Ochiq kirishOlmos
Litsenziya: cc-by
ABI
Annotatsiya
This analysis will not only more accurately determine the nature of the development of the metabolic syndrome, the progression of coronary artery disease, but will also help to identify the impact of 2019-nCoV infection on heart damage.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos5 ta foydalanilgan manba